Literature DB >> 10493713

Diffusion of new drugs in Danish general practice.

F H Steffensen1, H T Sørensen, F Olesen.   

Abstract

OBJECTIVES: There is a large variation in implementing research findings in clinical practice. We examined whether the concept of early or late adopters is universal for the diffusion of all new drugs, and whether it is associated with non-scientific factors in general practice.
METHODS: We identified all prescriptions for five new drugs from the population-based prescription database in North Jutland County, Denmark (490000 inhabitants) from 1993 to 1996, and calculated the period from release of the drugs to the issuing of the first prescription by each GP. Logistic regression was performed to predict early or late prescribing from physician characteristics, practice activity and the number of prescriptions, adjusted for age and sex.
RESULTS: The distributions of the diffusion time of the drugs by 95 solo practitioners were asymmetrical, with a long upper tail representing the late prescribers. The shape and slope of the diffusion curve were highly drug dependent. There was poor agreement of the three adopter categories (early, intermediate and late prescribers) between the five drugs (kappa < 0.35), but being a late prescriber was the most consistent condition. Late prescribing of tramadol, compared with intermediate prescribing, was associated with female physicians (odds ratio (OR) 5.7; 95% CI 1.5-21.3), smaller list size (OR 0.1; 95% CI 0.0-0.8), a strong general restrictive attitude to pharmacotherapy (OR 0.07; 95% CI 0.01-0.68) and a tendency to lower diagnostic activity per patient (OR 0.4; 95% CI 0.1-1.9).
CONCLUSIONS: The slope and shape of the diffusion curve are both dependent on physician and drug characteristics, but late prescribers share some common characteristics.

Entities:  

Mesh:

Year:  1999        PMID: 10493713     DOI: 10.1093/fampra/16.4.407

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  16 in total

1.  Prescribing new drugs: qualitative study of influences on consultants and general practitioners.

Authors:  M I Jones; S M Greenfield; C P Bradley
Journal:  BMJ       Date:  2001-08-18

2.  Correlates of spontaneous reporting of adverse drug reactions within primary care: the paradox of low prescribers who are high reporters.

Authors:  Anthony R Cox; Christopher Anton; Sarah E McDowell; John F Marriott; Robin E Ferner
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

3.  Does the early adopter of drugs exist? A population-based study of general practitioners' prescribing of new drugs.

Authors:  Torben Dybdahl; Morten Andersen; Jens Søndergaard; Jakob Kragstrup; Ivar Sønbø Kristiansen
Journal:  Eur J Clin Pharmacol       Date:  2004-10-21       Impact factor: 2.953

4.  Primary care physicians' adoption of new drugs is not associated with their clinical interests: a pharmacoepidemiologic study.

Authors:  Torben Dybdahl; Jens Søndergaard; Jakob Kragstrup; Ivar Sønbø Kristiansen; Morten Andersen
Journal:  Scand J Prim Health Care       Date:  2011-04-21       Impact factor: 2.581

5.  In with the new: the determinants of prescribing innovation by general practitioners in Ireland.

Authors:  Jane Bourke; Stephen Roper
Journal:  Eur J Health Econ       Date:  2011-04-19

6.  Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitors.

Authors:  K Behan; C Cutts; Susan E Tett
Journal:  Eur J Clin Pharmacol       Date:  2005-01-27       Impact factor: 2.953

7.  Patterns and predictors of physician adoption of new cardiovascular drugs.

Authors:  Timothy S Anderson; Wei-Hsuan Lo-Ciganic; Walid F Gellad; Rouxin Zhang; Haiden A Huskamp; Niteesh K Choudhry; Chung-Chou H Chang; Seth Richards-Shubik; Hasan Guclu; Bobby Jones; Julie M Donohue
Journal:  Healthc (Amst)       Date:  2017-10-21

8.  Characterizing early prescribers of newly marketed drugs in Canada: a population-based study.

Authors:  Anita Kozyrskyj; Colette Raymond; Amber Racher
Journal:  Eur J Clin Pharmacol       Date:  2007-03-23       Impact factor: 2.953

9.  Patient educational level and use of newly marketed drugs: a register-based study of over 600,000 older people.

Authors:  Syed Imran Haider; Kristina Johnell; Gunilla Ringbäck Weitoft; Mats Thorslund; Johan Fastbom
Journal:  Eur J Clin Pharmacol       Date:  2008-08-10       Impact factor: 2.953

10.  How quickly do physicians adopt new drugs? The case of second-generation antipsychotics.

Authors:  Haiden A Huskamp; A James O'Malley; Marcela Horvitz-Lennon; Anna Levine Taub; Ernst R Berndt; Julie M Donohue
Journal:  Psychiatr Serv       Date:  2013-04-01       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.